Radium 223 Dichloride

Radium 223 Dichloride is the generic name for the trade name drug Xofigo®. In some cases, health care professionals may use the trade name Xofigo® when referring to the generic drug name radium 223 dichloride.

What Radium 223 Dichloride Is Used For:

The treatment of patients with prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has spread to bones with symptoms, but not to other parts of the body.

Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.

How Radium 223 Dichloride Is Given:

Radium-223 dichloride is given through a vein (intravenously, IV), as a slow [intravenous] injection, over about 1 minute.

There is no pill form of radium-223 dichloride.

It is given in a clinic or facility where healthcare providers or technicians have been trained to give radiation therapy.

It is given once every 4 weeks for a maximum of 6 doses.

The amount of radium-223 dichloride that you will receive depends on many factors, including your weight, and your general health or other health problems. Your doctor will determine your exact dosage and schedule.

Side Effects:

Important things to remember about the side effects of radium-223 dichloride:

Most people will not experience all of the radium-223 dichloride side effects listed.

Radium-223 dichloride side effects are often predictable in terms of their onset, duration, and severity.

Radium-223 dichloride side effects will improve after therapy is complete.

Radium-223 dichloride side effects may be quite manageable. There are many options to minimize or prevent the side effects of radium-223 dichloride.

The following side effects are common (occurring in greater than 10%) for patients taking Radium 223 Dichloride:

Radium-223 dichloride is not currently indicated for use in women. However, if radium-223 dichloride is given to a woman, getting pregnant should be avoided and the woman should not breast feed. Pregnancy category X (radium-223 dichloride may cause fetal harm when given to a pregnant woman). This drug must not be given to a pregnant woman or a woman who intends to become pregnant. If a woman becomes pregnant while taking radium-223 dichloride, the medication must be stopped immediately and the woman given appropriate counseling).

Because of potential negative effects on the development of sperm cells associated with radiation, men who are sexually active should use condoms as well as have their female partners of reproductive potential to use a highly effective contraceptive method during treatment and for at least 6 months after completing treatment with radium-223 dichloride.

It is not known what effects radium-223 dichloride has on human fertility. There is a potential risk that radiation by radium-223 dichloride could impair fertility.

It is important to tell your doctor if you are incontinent (unable to control) urine or stool.

Self-Care Tips:

Keep your body fluids from coming in contact with family members or caregivers. Use gloves when touching body fluids.

Drink at least two to three quarts of fluid every 24 hours, unless you are instructed otherwise.

You may be at risk of infection so try to avoid crowds or people with colds, and report fever or any other signs of infection immediately to your health care provider.

Use an electric razor and a soft toothbrush to minimize risk of bleeding.

Avoid contact sports or activities that could cause injury.

To reduce nausea, take anti-nausea medications as prescribed by your doctor, and eat small, frequent meals.

Drink at least two to three quarts of fluid every 24 hours, unless you are instructed otherwise.

In general, drinking alcoholic beverages should be kept to a minimum or avoided completely. You should discuss this with your doctor.

Get plenty of rest.

Maintain good nutrition.

If you experience symptoms or side effects, be sure to discuss them with your health care team. They can prescribe medications and/or offer other suggestions that are effective in managing such problems.

Bathroom hygiene is important:

Radioactivity is present in urine and stool after treatment. Be sure to practice good personal hygiene while on treatment with radium-223 dichloride and for at least 1 week after the last injection. If incontinent of urine (unable to hold urine) a catheter might be necessary temporarily. If, incontinent of stool (unable to control bowel movements) this could be a contraindication for this type of therapy.

After going to the bathroom, be sure to wash your hands thoroughly and flush the toilet several times.

Promptly clean up spilled bodily waste, wearing gloves when you clean. Dispose of gloves as directed by the healthcare provider who gave you your radium-223 dichloride treatment. Wash your hands when you are finished.

Wash soiled clothing right away and wash separately from other clothing.

Monitoring and Testing:

You will be checked regularly by your doctor while you are taking radium-223 dichloride, to monitor side effects and check your response to therapy. Periodic blood work will be obtained to monitor your complete blood count (CBC) as well as the function of other organs (such as your kidneys and liver) these tests will be ordered by your doctor.

How Radium 223 Dichloride Works:

Radium-223 dichloride is a type of radiopharmaceutical. Radiopharmaceuticals are radioactive drugs. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in the diagnosis and treatment of many diseases. A radioactive tracer is a chemical compound with an attached radioactive isotope [a variant of a chemical element] that can be introduced into and tracked within the body. Through a complex process, these radioactive isotopes undergo radioactive decay, resulting in the emission of particles such as alpha or beta particles. Radioactive isotopes are used primarily either for their chemical properties or as a source of radiation. Radionuclides of similiar elements can serve as radioactive tracers because they are similar chemically to the non-radioactive elements. There are some radionuclides that are bone seeking radioisotopes and those radionuclides exhibit chemical behavior similar to calcium, allowing them to be absorbed in areas where cancer is present in the bone. Once in the bone, the radioisotope emits beta or alpha particles, which kill the nearby cancer cells.

Radium-223 dichloride is an alpha-particle emitting radio isotope. The drug mimics calcium and forms complexes with the bone mineral at sites of bone metastatses. It then emits alpha particles, causing the destruction of DNA in nearby cells, resulting in cancer cell death in the bone.

Note: We strongly encourage you to talk with your health care professional about your specific medical condition and treatments. The information contained in this website is meant to be helpful and educational, but is not a substitute for medical advice.

Update 9/9/13

Chemocare.com is designed to provide the latest information about chemotherapy to patients and their families, caregivers and friends. For information about the 4th Angel Mentoring Program visit www.4thangel.org